These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4678827)

  • 21. Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.
    Kato T; Katsuyama M; Karai N; Hirose A; Nakamura M; Katsube J
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):243-6. PubMed ID: 3086752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological effects of imipramine and desmethylimipramine in developing rats.
    Lapin IP; Osipova SV; Uskova NV; Stabrovski EM
    Psychopharmacologia; 1969; 14(4):255-65. PubMed ID: 5350628
    [No Abstract]   [Full Text] [Related]  

  • 24. Different mechanisms of drug-induced release of noradrenaline and its congeners alpha-methylnoradrenaline and metaraminol.
    Carlsson A; Waldeck B
    Eur J Pharmacol; 1968 Sep; 4(2):165-8. PubMed ID: 5723998
    [No Abstract]   [Full Text] [Related]  

  • 25. Blockade of norepinephrine uptake and related activities of cis- and trans-N,N'-bis-(1-naphthylmethyl)-1,4-cyclohexane bis-(methylamine) dihydrochloride.
    Lippmann W
    Biochem Pharmacol; 1970 May; 19(5):1709-17. PubMed ID: 5513951
    [No Abstract]   [Full Text] [Related]  

  • 26. Active uptake of tritiated metaraminol by mouse brain slices in vitro.
    Ross SB; Renyi AL
    Life Sci; 1966 Apr; 5(7):639-47. PubMed ID: 4381260
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of the dual amine uptake-concentration mechanisms of the adrenergic neurons by epsilon-aminocaproic acid.
    Obianwu HO
    J Pharm Pharmacol; 1967 Jan; 19(1):54-5. PubMed ID: 4382176
    [No Abstract]   [Full Text] [Related]  

  • 28. Blockade of heart 3H-norepinephrine up-take by 4-phenyl-1-aminotetralines: implications for the active conformation of imipramine-like drugs.
    Sarges R; Koe BK; Weissman A; Schaefer JP
    J Pharmacol Exp Ther; 1974 Dec; 191(3):393-402. PubMed ID: 4427286
    [No Abstract]   [Full Text] [Related]  

  • 29. Incorporation of imipramine into isolated rat peritoneal mast cells in vitro.
    Gripenberg J
    Acta Physiol Scand; 1974 Sep; 92(1):56-65. PubMed ID: 4547227
    [No Abstract]   [Full Text] [Related]  

  • 30. Blocking H 3 -Norepinephrine uptake and some guanethidine-induced effects with tricyclic psychotherapeutic drugs.
    Koe BK; Constantine JW
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):71-80. PubMed ID: 5010834
    [No Abstract]   [Full Text] [Related]  

  • 31. Dose of desipramine and in vivo accumulation of 1-(3)H-noradrenaline in the rat heart and vas deferens.
    Manara L; Luzzani F
    Commun Psychopharmacol; 1978; 2(3):243-50. PubMed ID: 699538
    [No Abstract]   [Full Text] [Related]  

  • 32. Blockade of norepinephrine uptake and other activities of 5-(3'-dimethylaminopropyl)-dibenzo(a,d) (1,4)cycloheptadiene hydrochloride (AY-8794) and structurally related compounds.
    Lippmann W
    Biochem Pharmacol; 1969 Oct; 18(10):2517-29. PubMed ID: 5403988
    [No Abstract]   [Full Text] [Related]  

  • 33. Blockade of norepinephrine uptake by N,N'-bis-(1-naphthylmethyl)-1,4-cyclohexane bis-(methylamine) dihydrochloride in rodents.
    Lippmann W
    Biochem Pharmacol; 1969 Oct; 18(10):2495-505. PubMed ID: 5403986
    [No Abstract]   [Full Text] [Related]  

  • 34. Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxy-DOPA.
    Sachs C; Jonsson G
    J Neurochem; 1972 Jun; 19(6):1561-75. PubMed ID: 5035304
    [No Abstract]   [Full Text] [Related]  

  • 35. The postnatal development of noradrenaline uptake in the adrenergic nerves of different tissues from the rat.
    Sachs C; de Champlain J; Malmfors T; Olson L
    Eur J Pharmacol; 1970 Jan; 9(1):67-79. PubMed ID: 5434295
    [No Abstract]   [Full Text] [Related]  

  • 36. The ineffectiveness of desipramine pretreatment on behavioral effects of 6-hydroxydopamine in nialamide-pretreated rats.
    Vetulani J; Reichenberg K; Wiszniowska G
    Psychopharmacologia; 1974; 38(2):173-80. PubMed ID: 4460073
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
    Carlsson A; Fuxe K; Hamberger B; Lindqvist M
    Acta Physiol Scand; 1966; 67(3):481-97. PubMed ID: 5967609
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of antidepressant drugs of the imipramine type on central 5-hydroxytryptamine neurotransmission.
    Meek J; Fuxe K; Andén NE
    Eur J Pharmacol; 1970 Mar; 9(3):325-32. PubMed ID: 4314847
    [No Abstract]   [Full Text] [Related]  

  • 39. In vivo inhibition of 3H-noradrenaline uptake by mouse brain slices in vitro.
    Ross SB; Renyi AL
    J Pharm Pharmacol; 1966 May; 18(5):322-3. PubMed ID: 4380004
    [No Abstract]   [Full Text] [Related]  

  • 40. [Uptake and storage of catecholamines by adrenergic fibers of the central and peripheral nervous system. II. Preferential retention of noradrenaline].
    L'Hermite P
    Arch Anat Microsc Morphol Exp; 1969; 58(3):257-82. PubMed ID: 4316936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.